Intellipharmaceutics International Inc. Quarterly Liabilities in CAD from Q4 2015 to Q4 2018

Taxonomy & unit: us-gaap: CAD and USD
Description: Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary: Intellipharmaceutics International Inc. quarterly Liabilities history and growth rate from Q4 2015 to Q4 2018.
Intellipharmaceutics International Inc. Liabilities for the quarter ending November 30, 2018 was CA$7.37M, a 5.16% increase year-over-year.

Liabilities, Quarterly (CAD)

Liabilities, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2018	7.37M	+362K	+5.16%	Nov 30, 2018	20-F/A	2019-03-04
Q4 2017	7.01M	+152K	+2.22%	Nov 30, 2017	20-F/A	2019-03-04
Q2 2017	6.97M			May 31, 2017	6-K	2017-07-11
Q1 2017	7.09M			Feb 28, 2017	6-K	2017-04-12
Q4 2016	6.86M	+1.5M	+27.9%	Nov 30, 2016	20-F	2018-03-01
Q4 2015	5.36M			Nov 30, 2015	20-F	2017-02-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.